News
Important Only
Google spotlights AI over hardware upgrades in unveiling new smartphones
Google steps up integration of AI into its hardware devicesPrices remain flat amid tariff uncertaintiesGoogle’s AI push has not led to market share gains so farBy Kenrick Cai Aug 20 (Reuters) - Alphabet’s GOOGL.O Google introduced on Wednesday a new lineup of Pixel smartphones and gadgets, intens...Reuters
Wed, Aug 20
Supertramp singer must 'Give a Little Bit' to ex-bandmates, US court rules
By Blake BrittainAug 20 (Reuters) - A U.S. appeals court said on Wednesday that British rock band Supertramp's former singer and songwriter Roger Hodgson owes three other former band members a share of songwriting royalties that he stopped paying them in 2018.In a decision sprinkled with nods to...Reuters
Wed, Aug 20
Halliburton Enters $3.5 Billion Five Year Credit Agreement
Aug 20 (Reuters) - Halliburton Co HAL.N:HALLIBURTON CO - ENTERS $3.5 BILLION FIVE YEAR CREDIT AGREEMENT - SEC FILINGHALLIBURTON CO - 2025 CREDIT AGREEMENT REPLACES 2022 CREDIT AGREEMENT - SEC FILINGSource text: [ID:n0000045012-25-000062]Reuters
Wed, Aug 20
UnitedHealth Group Establishes Public Responsibility Committee
Aug 20 (Reuters) - UnitedHealth Group Inc UNH.N:UNITEDHEALTH GROUP INC - ESTABLISHES PUBLIC RESPONSIBILITY COMMITTEE - SEC FILINGUNITEDHEALTH GROUP INC - F. WILLIAM MCNABB APPOINTED LEAD INDEPENDENT DIRECTOR - SEC FILINGUNITEDHEALTH GROUP INC - MICHELE HOOPER TO CHAIR PUBLIC RESPONSIBILITY COMMITTEE...Reuters
Wed, Aug 20
Entergy receives regulatory approval for investments to support Meta's data center
Aug 21 (Reuters) - Entergy's ETR.N Louisiana unit received approval from the Louisiana Public Service Commission to move forward with infrastructure investments tied to Meta's new data center in Richland Parish, the company said on Wednesday.Reuters
Wed, Aug 20
Cardiol Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview
Cardiol Therapeutics Inc CRDL.TO is expected to show no change in quarterly revenue when it reports results on November 12 (estimated) for the period ending September 30 2025LSEG's mean analyst estimate for Cardiol Therapeutics Inc is for a loss of 11 cents per share. The current average ana...Reuters
Wed, Aug 20
NurExone Biologic Announces Preclinical Evidence of Structural Repair In Injured Spinal Cord Tissue Following ExoPTEN Treatment
Aug 20 (Reuters) - Nurexone Biologic Inc NRX.V:NUREXONE BIOLOGIC ANNOUNCES PRECLINICAL EVIDENCE OF STRUCTURAL REPAIR IN INJURED SPINAL CORD TISSUE FOLLOWING EXOPTEN TREATMENTReuters
Wed, Aug 20
Rhythm Pharmaceuticals Announces FDA Acceptance Of sNDA For Setmelanotide In Acquired Hypothalamic Obesity
Aug 20 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O:RHYTHM PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF SNDA FOR SETMELANOTIDE IN ACQUIRED HYPOTHALAMIC OBESITYRHYTHM PHARMACEUTICALS INC - FDA GRANTS PRIORITY REVIEW WITH PDUFA DATE DECEMBER 20, 2025RHYTHM PHARMACEUTICALS INC - STUDY MET PRIMARY ENDPO...Reuters
Wed, Aug 20
Invivyd Announces Proposed Public Offering Of Common Stock
Aug 20 (Reuters) - Invivyd Inc IVVD.O:INVIVYD ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCKINVIVYD INC - CANTOR ACTING AS SOLE BOOK-RUNNING MANAGER FOR INVIVYD OFFERINGINVIVYD : GRANTS UNDERWRITERS OPTION FOR 30 DAYS TO PURCHASE UP TO 15% OF CO'S COMMON STOCK SOLD IN PUBLIC OFFERINGReuters
Wed, Aug 20
